People's Government of Minhang District, Shanghai: Helping enterprises to go out and encourage foreign trade enterprises to expand their business. The People's Government of Minhang District issued the Policy Opinions on High-quality Industrial Development in Minhang District (Trial), which pointed out that helping enterprises to go out. Support enterprises to purchase export credit insurance products and build or rent overseas warehouses overseas. Encourage foreign trade enterprises to expand their business and give certain financial support to enterprises that reach a certain scale. Support new energy vehicles, used cars, photovoltaics and other enterprises to expand overseas markets. Support the development of cross-border e-commerce. Support the development, maintenance and system construction of enterprises to build or dock cross-border e-commerce platforms. Encourage enterprises to export business in cross-border e-commerce mode. Encourage enterprises to deeply participate in the creation of the "Silk Road E-commerce" cooperation pioneer zone.In 2024, the qualification examination and approval of the first batch of new materials insurance compensation was started, and the Ministry of Industry and Information Technology recently issued a notice to organize the qualification examination and approval of the first batch of new materials insurance compensation in 2024. It is clear that the enterprise applying for qualification should be an enterprise that produces and manufactures the products listed in the Catalogue for the Demonstration and Guidance of the First Application of Key New Materials (2024 Edition). It belongs to an independent legal person registered in People's Republic of China (PRC), has strong design and development, manufacturing and industrialization capabilities, has a relatively complete team of professional technicians, and has mastered the core technology and intellectual property rights of this product development. The qualification examination and approval procedures need to go through three steps: enterprise declaration, review by local industrial and information authorities or recommended units such as the central enterprise group, and expert review organized by the Ministry of Industry and Information Technology. After review, the product compensation qualification is determined, and the amount of subsidy funds is approved according to a certain proportion of the product value, and the effective period is no more than 3 years.The tenth batch of national mining companies officially opened their bids in Shanghai, and on December 12, the tenth batch of national mining companies officially opened their bids in Fengxian District, Shanghai. According to the schedule of on-site publicity, the application materials will be accepted centrally from 8: 00 am to 10: 00 am, and the application information will be made public from 10: 00 am. Some business representatives said that this national adoption was the largest number of participants over the years. Some business representatives also said that they would respond to the call of the National Medical Insurance Bureau with the greatest sincerity. At the scene, there were also business representatives joking. Today, they specially wore red clothes, which meant that they could win the victory. (21 Finance)
Wei Lanfeng became the vice president and chief operating officer of Porsche China, and Porsche announced that Philipp von Witzendorff will officially become the vice president and chief operating officer of Porsche China from January 1st, 2025. It is understood that in the past two years, Wei Lanfeng has served as President and CEO of Porsche Japan.Zhejiang has published a list of the top 500 enterprises. According to the news released by Zhejiang in WeChat official account, Zhejiang Institute of Science and Technology Information organized the evaluation of innovation ability of high-tech enterprises, and recently selected the top 500 high-tech enterprises in Zhejiang Province in 2024. Among them, Hangzhou Hikvision Digital Technology Co., Ltd., Ningbo Oaks Electric Co., Ltd. and Xinhua San Technology Co., Ltd. are in the top three.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.
In the concept of ice and snow economy, there were many daily limit changes, such as iceberg cold and hot, iceberg cold and hot, Longjian shares and Jingxue energy-saving daily limit, and Dalian Shengya, Changbai Mountain, Yeti shares and Sante ropeway were among the top gainers.Chuanrun helps Goldwind Technology roll off the production line of a new generation of deep-sea 22MW offshore wind turbines. According to Sichuan Chuanrun Co., Ltd., recently, Goldwind Technology successfully rolled off the production line of a new generation of deep-sea 22MW offshore wind turbines in Shantou manufacturing base, setting a new record for Guangdong's largest single-unit capacity offshore wind turbines. As a key technical partner, Chuanrun provided a complete set of cooling system and lubrication system for the unit, which demonstrated the company's technical strength and innovation ability in the field of wind power.The trading of traditional Chinese medicine has increased the daily limit of Panlong Pharmaceutical, the trading of traditional Chinese medicine has increased, Panlong Pharmaceutical has increased its daily limit, Xiangxue Pharmaceutical has increased by over 9%, and Kunyao Group, Weikang Pharmaceutical, Huasen Pharmaceutical and Xinguang Pharmaceutical have followed suit.
Strategy guide
12-14
Strategy guide 12-14
Strategy guide